(Q42965863)

11 November 2017

Deletion of PTENP1 pseudogene in human melanoma (English)

1 reference

11 November 2017

1

1 reference

11 November 2017

7

1 reference

11 November 2017

Adele Haimovic

2

1 reference

11 November 2017

Paul J Christos

3

1 reference

11 November 2017

Eleazar C Vega Y Saenz de Miera

4

1 reference

11 November 2017

Richard Shapiro

5

1 reference

11 November 2017

Anna Pavlick

6

1 reference

11 November 2017

Farbod Darvishian

8

1 reference

11 November 2017

Iman Osman

9

1 reference

11 November 2017

language of work or name

English

0 references

publication date

11 August 2011

1 reference

Journal of Investigative Dermatology

11 November 2017

1 reference

11 November 2017

131

1 reference

11 November 2017

12

1 reference

11 November 2017

2497-2500

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2011.232

11 November 2017

0 references

cites work

Haplo-insufficiency: a driving force in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

Posttranscriptional regulation of PTEN dosage by noncoding RNAs

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

Smoke and miRrors: pseudogenes tricking miRNAs

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

Bim-targeted cancer therapy: a link between drug action and underlying molecular changes.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

How to make a melanoma: what do we know of the primary clonal events?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3213301

PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo

26 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21833010

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

10q deletions in metastatic cutaneous melanoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21833010

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FJID.2011.232

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JID.2011.232

1 reference

11 November 2017

1 reference

11 November 2017

PubMed publication ID

21833010

1 reference